1,932 results match your criteria Cardiovascular Revascularization Medicine [Journal]


Temporal trends and outcomes of transcatheter mitral valve repair and surgical mitral valve intervention.

Cardiovasc Revasc Med 2020 May 23. Epub 2020 May 23.

Division of Cardiovascular Medicine, Baylor School of Medicine, Houston, TX, United States of America. Electronic address:

Background: There is a paucity of data regarding the contemporary changes in the uptake and outcomes of transcatheter mitral valve repair (TMVR) and surgical mitral valve repair/replacement (SMVR).

Methods: We queried the NIS database (2012-2016) to identify hospitalizations for TMVR and SMVR. We reported the temporal trends for uptake of TMVR and SMVR and their in-hospital outcomes. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.05.021DOI Listing

Long-term mortality comparison of patients with acute myocardial infarction complicated by cardiogenic shock and treated with culprit-only or multivessel percutaneous coronary intervention.

Cardiovasc Revasc Med 2020 Jun 18. Epub 2020 Jun 18.

Division of Cardiology, Careggi-Hospital, Florence, Italy.

Objectives: We sought to determine whether, in a real word context of patients with Acute Myocardial Infarction (AMI), multivessel disease (MVD) and cardiogenic shock (CS), the successful treatment with primary percutaneous coronary intervention (p-PCI) of only culprit lesions (OC-PCI) is associated with better long-term mortality rates than multivessel PCI (MV-PCI) of all significant lesions.

Methods: From our registry of all consecutive patients admitted for AMI between January 1995 and December 2016 we selected those presenting with CS and MVD successfully treated with p-PCI, and compared those who underwent OC-PCI against MV-PCI, either during the p-PCI (MV-pPCI) or by staged revascularization (Staged-PCI) during hospitalization. The primary endpoint was 2-year all-cause death. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.06.021DOI Listing

Impella versus extracorporeal membrane oxygenation for acute myocardial infarction cardiogenic shock.

Cardiovasc Revasc Med 2020 May 30. Epub 2020 May 30.

Department of Cardiology, Henry Ford Hospital, Detroit, MI, United States of America.

Background: Percutaneous ventricular assist devices and extracorporeal membrane oxygenation (ECMO) are increasingly used for mechanical circulatory support (MCS) in patients with acute myocardial infarction with cardiogenic shock (AMI-CS) in hospitals throughout the United States.

Methods: Using the National Inpatient Sample from October 2015 to December 2017, we identified hospital admissions that underwent percutaneous coronary intervention (PCI) and non-elective Impella or ECMO placement for AMI-CS using ICD-10 codes. Propensity-score matching was performed to compare both groups for primary and secondary outcomes. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.05.042DOI Listing

Partial sub-struts stenting technique for emergency treatment of very late LAD stent thrombosis: A case report.

Cardiovasc Revasc Med 2020 May 29. Epub 2020 May 29.

Department of Heart and Great Vessels, Sapienza University of Rome, Rome, Italy.

Although rare, stent thrombosis remains a severe complication after stent implantation owing to its high morbidity and mortality, and represents a challenging scenario for interventional cardiology. Sub-struts stenting could constitute a rare last-resort-bailout technique for recanalization. We present herein a case of acute coronary syndrome secondary to in-stent restenosis and very late thrombosis, successfully treated with a partial sub-struts stenting. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.05.037DOI Listing

Will We Ever Decide What Antithrombotic Regimen to Use After Stenting?

Authors:
Spencer B King

Cardiovasc Revasc Med 2020 May;21(5):702-703

5665 Peachtree Dunwoody Road NE, Atlanta, GA 30342. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.05.026DOI Listing

Time-to-Event Meta-Analysis - Time to Do it Right!

Cardiovasc Revasc Med 2020 May;21(5):692-693

Section of Interventional Cardiology, Medstar Washington Hospital Center,Washington, DC. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.05.023DOI Listing

The Jury Is Still Out on Atherectomy.

Cardiovasc Revasc Med 2020 May;21(5):682-683

Department of Cardiology, Loyola University MedicalCenter, 2160 S 1st Ave, Maywood, IL 60153; Department of Cardiology, Edward Hines Jr VA Hospital,5000 5th Ave, Hines, IL 60141. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.05.024DOI Listing

Editorial: Revisiting Fluoroscopic-Guided Femoral Access.

Cardiovasc Revasc Med 2020 May;21(5):675

Department of Cardiology, Loyola University Medical Center, Maywood, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.05.025DOI Listing

Mechanical Circulatory Support with the Impella Family: Festina Lente.

Cardiovasc Revasc Med 2020 May;21(5):638-639

Central Arkansas Veterans Health System, University of Arkansas for Medical Sciences, Little Rock, AR. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.05.022DOI Listing

Axillary access TAVR: Entrapment of a transcatheter aortic valve in the innominate artery with aortic dissection.

Cardiovasc Revasc Med 2020 Jun 18. Epub 2020 Jun 18.

Department of Advanced Cardiopulmonary Therapies and Transplantation, McGovern Medical School, University of Texas Health Science Center-Houston and Memorial Hermann Hospital-Texas Medical Center, 6400 Fannin, Suite 2350, Houston, TX 77030, United States of America. Electronic address:

Non-femoral transcatheter aortic valve replacement (TAVR) is indicated when peripheral vascular disease is diagnosed. We describe the "double-stick" technique via the axillary artery. During the procedure, the pigtail coiled around the TAVR system. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.06.020DOI Listing

Transulnar catheterization in patients with failed ipsilateral transradial access: Novel TR band modification for dual site hemostasis.

Cardiovasc Revasc Med 2020 Jun 20. Epub 2020 Jun 20.

Department of Cardiology, Mount Sinai Beth Israel, 16th Street and 1st Avenue, New York, NY 10003, USA. Electronic address:

Objectives: This study investigated the feasibility and safety of transulnar access (TUA) and efficacy of novel TR band modification for dual site hemostasis in patients with failed ipsilateral transradial approach.

Background: Failed transradial access requires cross over to alternative access site. There is paucity of data on feasibility and safety of ipsilateral TUA due to concern of potential risk of hand ischemia. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.06.018DOI Listing

Cerebral embolic protection for TAVR: Don't let it go to your head.

Cardiovasc Revasc Med 2020 Apr 3. Epub 2020 Apr 3.

Lifespan Cardiovascular Institute and Warren Alpert Medical School of Brown University, Providence, RI, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.03.031DOI Listing

Machine-learning-based in-hospital mortality prediction for transcatheter mitral valve repair in the United States.

Cardiovasc Revasc Med 2020 Jun 15. Epub 2020 Jun 15.

Center for Collaborative Research in Health Disparities, University of Puerto Rico School of Medicine, San Juan, PR, USA.

Background: Transcatheter mitral valve repair utilization has increased significantly in the United States over the last years. Yet, a risk-prediction tool for adverse events has not been developed. We aimed to generate a machine-learning-based algorithm to predict in-hospital mortality after TMVR. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.06.017DOI Listing

Clinician perceptions of the impact of a shock team approach in the management of cardiogenic shock: A qualitative study.

Cardiovasc Revasc Med 2020 Jun 15. Epub 2020 Jun 15.

Barts Health NHS Trust, London, United Kingdom; William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom. Electronic address:

Introduction: Designated cross-specialty shock teams have been proposed as a mechanism to manage the complexity of decision-making and facilitate collaborative, patient-centred care-planning in cardiogenic shock. Observational data support the notion that shock protocols and teams may improve survival, but there is an absence of data interrogating how clinicians engage with and value the shock team paradigm. This study sought to explore clinician perceptions of the value of the shock call system on decision making and the management of CGS. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.06.011DOI Listing

Evaluation of railway sheathless access system for transradial coronary and peripheral interventions.

Cardiovasc Revasc Med 2020 Jun 15. Epub 2020 Jun 15.

Department of Interventional Cardiology, Deborah Heart & Lung Center, United States of America. Electronic address:

Objective: Evaluate efficacy and safety of Railway Sheathless Access System™ (Railway) in the first 200 consecutive cases at our center.

Background: Transradial Intervention (TRI) is limited by the frequent occurrence of spasm, radial artery occlusion (RAO) and inability to use larger guide catheters (GC). The small size of radial artery (RA) is the primary reason for these limitations. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.06.016DOI Listing

Periprocedural myocardial injury: Pathophysiology, prognosis, and prevention.

Cardiovasc Revasc Med 2020 May 26. Epub 2020 May 26.

MedStar Washington Hospital Center, Washington, DC, USA. Electronic address:

The definition and clinical implications of myocardial infarction occurring in the setting of percutaneous coronary intervention have been the subject of unresolved controversy. The definitions of periprocedural myocardial infarction (PMI) are many and have evolved over recent years. Additionally, the recent advancement of different imaging modalities has provided useful information on a patients' pre-procedural risk of myocardial infarction. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.04.011DOI Listing

Coronary and structural heart disease interventions during COVID-19 pandemic: A road map for clinicians and health care delivery systems.

Cardiovasc Revasc Med 2020 Jun 10. Epub 2020 Jun 10.

Geisinger Medical Center, Danville, PA, United States of America.

Background: Because of the COVID-19 pandemic, cath labs have had to modify their workflow for elective and urgent patients.

Methods: We surveyed 16 physicians across 3 hospitals in our healthcare system to address COVID-19 related concerns in the management of interventional and structural heart disease patients, and to formulate system wide criteria for deferring cases till after the pandemic.

Results: Our survey yielded common concerns centered on the need to protect patients, cath lab staff and physicians from unnecessary exposure to COVID-19; for COVID-19 testing prior to arrival to the cath lab; for clear communication between the referring physician and the interventionalist; but there was initial uncertainty among physicians regarding the optimal management of ST elevation myocardial infarction (STEMI; percutaneous coronary intervention versus thrombolytics). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.06.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286249PMC

IntravaScular lithotripsy for the Management of undILatable coronary stEnt: The SMILE Registry.

Cardiovasc Revasc Med 2020 May 23. Epub 2020 May 23.

Clinical and Interventional Cardiology Unit, Istituto Clinico S.Ambrogio, Milan, Italy.

Background: Intravascular lithotripsy (IVL) showed to be effective in dilating heavily calcified de novo coronary lesions but little is known about its performance in under-expanded stents management. Aim of this study was to assess the feasibility, effectiveness and safety of IVL for the treatment of stent underexpansion refractory to balloon dilatation.

Methods: A multicentre, retrospective cohort analysis was performed in patients undergoing IVL to treat under-expanded stents following non-compliant balloon expansion failure. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.05.020DOI Listing

Trends, predictors, and outcomes associated with 30-day hospital readmissions after percutaneous coronary intervention in a high-volume center predominantly using radial vascular access.

Cardiovasc Revasc Med 2020 May 22. Epub 2020 May 22.

Division of Cardiovascular Medicine, Department of Medicine, University of Massachusetts Medical School, Worcester, MA, United States of America. Electronic address:

Background And Aim: Patients undergoing percutaneous coronary intervention (PCI) are at high-risk for hospital readmission. We examined the rate, factors associated with, and outcomes of 30-day readmissions for patients who underwent a PCI.

Methods: We reviewed medical records of all patients who underwent PCI between 2011 and 2014 at a central New England radial first, tertiary care center. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.05.017DOI Listing

Very early changes in quality of life after transcatheter aortic valve replacement: Results from the 3M TAVR trial.

Cardiovasc Revasc Med 2020 Jun 3. Epub 2020 Jun 3.

University of Missouri-Kansas City, Kansas City, MO, USA.

Background: Patients with severe, symptomatic aortic stenosis derive substantial 30-day quality of life (QOL) benefit from transcatheter aortic valve replacement (TAVR). Whether the QOL benefit of TAVR emerges earlier is unknown. We used data from the Multimodality, Multidisciplinary but Minimalist (3M) TAVR study to assess early changes in QOL after transfemoral (TF) TAVR. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.05.044DOI Listing

Outcomes with combined laser atherectomy and intravascular brachytherapy in recurrent drug-eluting in-stent restenosis.

Cardiovasc Revasc Med 2020 Jun 13. Epub 2020 Jun 13.

Minneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, MN, USA. Electronic address:

Background: Recurrent drug-eluting stents (DES) in-stent restenosis (ISR) can be challenging to treat. The combined use of excimer laser atherectomy (ELCA) and vascular brachytherapy (VBT) for this indication has received limited study.

Methods: We report the long-term outcomes of patients with recurrent DES ISR treated with combined VBT and ELCA from January 2014 to September 2018 at a single institution. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.06.019DOI Listing

Editorial: Optimizing PCI Outcomes by Determining Frailty Risk.

Cardiovasc Revasc Med 2020 May 1. Epub 2020 May 1.

Wiltshire Cardiac Centre, Marlborough Road, Swindon, SN36BB, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.04.038DOI Listing

Cardiac amyloidosis in patient undergoing TAVR, why we need to think about it.

Cardiovasc Revasc Med 2020 Jun 10. Epub 2020 Jun 10.

Division of Interventional Structural Cardiology, Cardiothoracovascular Department, Careggi University Hospital, Florence, Italy.

Systemic amyloidosis encompasses a variety of diseases characterized by extracellular deposition of protein-derived fibrils in different tissues and organs. Immunoglobulin light-chain (AL) and transthyretin (ATTR) amyloid are the two types that more commonly affect the heart and in both subtypes cardiac involvement is the main determinant of prognosis. Recently, several studies have suggested that Cardiac Amyloidosis (CA) and Aortic Stenosis (AS) can coexist more frequently than previously suspected with prevalence ranging from 5,6% to 16% in different cohorts. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.06.005DOI Listing

Does a complex recanalization of a chronic total occlusion remain complex after discharge?

Authors:
Gerald S Werner

Cardiovasc Revasc Med 2020 Jun 9. Epub 2020 Jun 9.

Medizinische Klinik (Cardiology & Intensive Care), Klinikum Darmstadt GmbH, Darmstadt, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.06.007DOI Listing

Complete versus culprit-only revascularization in patients presenting with ST-segment elevation myocardial infarction: A meta-analysis of randomized control trials.

Cardiovasc Revasc Med 2020 May 21. Epub 2020 May 21.

Division of Cardiology, Southern Illinois University School of Medicine, United States of America.

Background: In patients with ST elevation myocardial infarction (STEMI), primary percutaneous coronary intervention (PCI) of the culprit vessel is the preferred treatment option. For patients with multivessel disease, the benefit of revascularization of the non-culprit artery is not well known. This meta-analysis aims to assess the efficacy and safety of complete versus culprit vessel only revascularization. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.05.019DOI Listing

Intra-arterial hemodynamics to guide the percutaneous treatment of a difficult to engage transplant renal artery stenosis.

Cardiovasc Revasc Med 2020 Jun 11. Epub 2020 Jun 11.

Cardiovascular Medicine Division, The University of Toledo, Toledo, OH, USA. Electronic address:

Transplant renal artery stenosis (TRAS) is the most frequent vascular complication after renal transplantation. TRAS is associated with resistant hypertension and allograft dysfunction, early diagnosis and either endovascular or surgical treatment is crucial to preserve graft function. Noninvasive imaging can usually detect the underlying stenosis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.06.009DOI Listing

Early post-percutaneous coronary intervention chest pain: A nationwide survey on interventional cardiologists' perspective.

Cardiovasc Revasc Med 2020 May 16. Epub 2020 May 16.

Department of Internal Medicine, East Tennessee State University, Johnson City, TN, USA. Electronic address:

Background: Early post-percutaneous coronary intervention chest pain (EPPCP) appears to be a common clinical phenomenon. EPPCP has not been fully explained or studied in the literature despite the abundance of clinical trials on percutaneous coronary intervention (PCI). The objective of this questionnaire-based survey is to assess the current perception of EPPCP among practicing interventional cardiologists nationwide. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.05.011DOI Listing

Shockwave™ lithoplasty in combination with atherectomy in treating severe calcified femoropopliteal and iliac artery disease: A single center experience.

Cardiovasc Revasc Med 2020 Jun 11. Epub 2020 Jun 11.

Midwest Cardiovascular Research Foundation, Davenport, IA, United States of America.

Background: Calcium is a predictor of poor outcome in the treatment of infrainguinal arterial disease. Rotational atherectomy can effectively debulk atherosclerotic calcium but is less likely to significantly modify medial and adventitial calcinosis. Shockwave IVL provides circumferential sonic pressure waves capable of disrupting deeper calcium and theoretically complements the debulking process of atherectomy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.06.015DOI Listing

Statin adherence and poverty - The wide gap in cardiovascular prevention.

Cardiovasc Revasc Med 2020 Jun 10. Epub 2020 Jun 10.

All India Institute of Medical Sciences, Rishikesh, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.06.012DOI Listing

Endovascular intervention for the treatment of Trans-Atlantic Inter-Society Consensus (TASC) D femoropopliteal lesions: A systematic review and meta-analysis.

Cardiovasc Revasc Med 2020 Jun 12. Epub 2020 Jun 12.

Division of Cardiology, Rocky Mountain Regional VA Medical Center, University of Colorado, Denver, CO, USA. Electronic address:

Purpose: Advancements in the endovascular treatment of femoropopliteal atherosclerotic lesions have led to treatment of more complex lesions, particularly long lesions. The aim of this study was to determine the meta-analytic primary patency and need for re-intervention among patients treated for very long lesions (>200 mm) at the femoropopliteal segment and to identify potential risk factors for loss of patency.

Methods: This study was performed according to the PRISMA guidelines. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.06.014DOI Listing

The Fragmentation of Interventional Cardiology.

Authors:
Spencer B King

Cardiovasc Revasc Med 2020 Apr;21(4):565

5665 Peachtree Dunwoody Road NE, Atlanta, GA 30342. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.03.005DOI Listing

Renal Sympathetic Denervation for Hypertension: Outside-In and Inside-Out.

Cardiovasc Revasc Med 2020 Apr;21(4):538-539

Division of Cardiology, Massachusetts General Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.03.006DOI Listing

The Enigma of Optimal Treatment for Large Intracardiac and Intravascular Thrombus.

Authors:
On Topaz

Cardiovasc Revasc Med 2020 Apr;21(4):494-495

Professor of Medicine, Duke University School of Medicine, Division of Cardiology, Charles George Veterans Affairs Medical Center, Asheville, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.04.009DOI Listing

Unilateral Femoral Access for Transfemoral Approach in Transcatheter Aortic Valve Replacement: The Happy Medium?

Cardiovasc Revasc Med 2020 Apr;21(4):486-488

Division of Cardiology, Rocky Mountain Regional VA Medical Center, University of Colorado, Denver, CO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.03.004DOI Listing

Practice makes Perfect: What have We Learned from Many Years of Experience with the WATCHMAN?

Cardiovasc Revasc Med 2020 Apr;21(4):473-474

Division of Cardiology and the Department of Medicine, Virginia Commonwealth University School of Medicine, Richmond, VA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.03.007DOI Listing

What Pooling Data Tells Us, or Not, About Using TAVR in the Population at Low Surgical Risk for Mortality.

Cardiovasc Revasc Med 2020 Apr;21(4):439-440

Professor of Cardiothoracic Surgery Allison Family Distinguished Chair of Cardiovascular Research Houston Methodist Hospital 6550 Fannin, Suitre 1401 Houston, TX 77030. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.03.008DOI Listing

National trends of outcomes in transcatheter aortic valve replacement (TAVR) through transapical versus endovascular approach: From the National Inpatient Sample (NIS).

Cardiovasc Revasc Med 2020 May 15. Epub 2020 May 15.

Advocate Illinois Masonic Medical Center, Chicago, IL, United States of America; University of California, San Francisco, San Francisco, CA, United States of America.

Background: To evaluate the trends in complication rates following transcatheter aortic valve replacement (TAVR) procedures according to the type of vascular approach (endovascular vs. transapical) in a large US population sample.

Methods: The National Inpatient Sample (NIS) was queried for all patients diagnosed with aortic stenosis who underwent a TAVR procedure in the United States during the years 2012-2016. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.05.010DOI Listing

Evaluation of the DAPT score in patients who undergo percutaneous coronary intervention in England and Wales.

Cardiovasc Revasc Med 2020 May 6. Epub 2020 May 6.

Keele Cardiovascular Research Group, Keele University, Stoke-on-Trent, United Kingdom; Department of Cardiology, Royal Stoke University Hospital, Stoke-on-Trent, United Kingdom. Electronic address: https://twitter.com/MMamas1973.

This study aims to evaluate the temporal changes in DAPT score and determine whether there is an association between DAPT score and mortality. We analyzed all patients who underwent PCI in England and Wales 2007-2014. Statistical analyses were performed evaluating the DAPT score according to ≥2 and <2 cutoffs. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.05.003DOI Listing

Prosthetic valve endocarditis in patients undergoing TAVR compared to SAVR: A systematic review and meta-analysis.

Cardiovasc Revasc Med 2020 May 25. Epub 2020 May 25.

Thomas Jefferson University, PA, USA. Electronic address:

Background: The risk of prosthetic valve endocarditis (PVE) in patients who underwent transcatheter aortic valve replacement (TAVR) is presumed to be high.

Methods: Electronic databases were searched to identify articles comparing the rate of PVE in post-TAVR and post-surgical aortic valve replacement (SAVR) patients. Pooled adjusted odds ratio (OR) was computed using a random-effects model. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.05.034DOI Listing

Impact of early (≤24 h) versus delayed (>24 h) intervention in patients with non-ST segment elevation myocardial infarction: An observational study of 20,882 patients from the London Heart Attack Group.

Cardiovasc Revasc Med 2020 Jun 3. Epub 2020 Jun 3.

Department of Cardiology, Royal Brompton & Harefield NHS Foundation Trust, Harefield Hospital, Hill End Road, Middlesex UB9 6JH, UK.

Introduction: We aimed to investigate the optimal timing of invasive coronary angiography and subsequent intervention in non-ST-segment elevation acute myocardial infarction (NSTEMI) patients.

Methods: We examined the impact of early (≤24 h) versus delayed (>24 h) intervention in a large observational cohort of 20,882 consecutive NSTEMI patients treated with PCI between 2005 and 2015 at 8 tertiary cardiac centers in London (UK) using Cox-regression analysis and propensity matching.

Results: Mean age was 64. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.06.001DOI Listing

Safety and efficacy of colchicine in patients with coronary artery disease: A systematic review and meta-analysis.

Cardiovasc Revasc Med 2020 Jun 6. Epub 2020 Jun 6.

Division of Cardiology, Department of Medicine, Thomas Jefferson University, Philadelphia, PA, USA.

Background: Given current evidence, the use of colchicine for the prevention of adverse cardiovascular events in patients with coronary artery disease (CAD) remains controversial.

Methods: Multiple databases were queried to identify studies comparing the safety and efficacy of colchicine in patients with acute coronary syndrome (ACS) or stable angina. The relative risk (RR) of major adverse cardiovascular events (MACE) and gastrointestinal (GI) adverse events were calculated using a random-effect model. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.06.004DOI Listing

Impact of intravascular brachytherapy on patient reported outcomes in patients with coronary artery disease.

Cardiovasc Revasc Med 2020 Jun 6. Epub 2020 Jun 6.

University Medical Center, Phoenix, AZ, USA. Electronic address:

Background: Intravascular brachytherapy (VBT) is an established treatment for the management of in-stent restenosis (ISR). However, whether VBT is associated with improved patient reported outcomes unknown.

Methods: We evaluated 51 consecutive patients undergoing VBT in one or more coronary arteries from January 2018 to September 2019. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.05.032DOI Listing

Left main coronary interventions: A practical guide.

Cardiovasc Revasc Med 2020 May 20. Epub 2020 May 20.

The Spencer B. King III Catheterization Laboratory, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.

Coronary artery bypass surgery has been the accepted treatment for left main coronary artery disease for over 50 years. Balloon angioplasty was later used then abandoned because of deaths likely due to restenosis or thrombotic occlusion. However, rapid innovations in drug-eluting stent designs leading to more biocompatible thin strut platforms with optimal drug elution profiles and further advances in modern pharmacotherapy involving potent P2Y inhibitors combined with utilization of intracoronary imaging and physiologic assessment for procedural planning and optimization have transformed percutaneous interventions into successful alternatives to coronary artery bypass graft surgery (CABG) in selected LM anatomic territories. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.05.014DOI Listing

Balloon aortic valvuloplasty followed by Impella®-assisted left main coronary artery percutaneous coronary intervention in patients with severe aortic stenosis as a bridge to transcatheter aortic valve replacement.

Cardiovasc Revasc Med 2020 Jun 3. Epub 2020 Jun 3.

Department of Medicine, Division of Cardiology, NorthShore University HealthSystem, 9650 Gross Point Road, Skokie, IL 60076, USA.

Background: The use of Impella® to provide hemodynamic support during unprotected left main coronary artery (LMCA) percutaneous coronary intervention (PCI) has been shown to be feasible, but severe AS is a relative contraindication for its use. Balloon aortic valvuloplasty (BAV) may facilitate the use of Impella® in these patients.

Objective: To assess the feasibility of BAV followed by Impella®-assisted LMCA PCI in patients with severe AS as bridge to TAVR. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.06.003DOI Listing

Platypnea-Orthodeoxia Syndrome: Rare or under-diagnosed syndrome? 3 case reports and a literature review.

Cardiovasc Revasc Med 2020 Jun 5. Epub 2020 Jun 5.

Memorial Healthcare System, Department of Graduate Medical Education, Internal Medicine, 703 North Flamingo Road, Pembroke Pines, FL 33028, United States of America; Memorial Healthcare System, Memorial Cardiac and Vascular Institute, 1150 N 35th Avenue, Suite 605, Hollywood, FL 33021, United States of America. Electronic address:

Platypnea-Orthodeoxia Syndrome (POS) is dyspnea and hypoxemia in the upright position that improves in the supine position. Cardiac POS is predominantly caused by congenital interatrial communications (CIC) paired with changes in the thoracic anatomy, allowing orthostatic right to left cardiac shunting. High suspicion, especially with hypoxemia without significant pulmonary disease, that does not easily correct with supplemental oxygen, should lead the clinician to obtain echocardiographic imaging, documenting right to left shunting, typically through a patent foramen ovale (PFO). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.06.002DOI Listing

A permanent common carotid filter for stroke prevention in atrial fibrillation: Ex vivo and in vivo pre-clinical testing.

Cardiovasc Revasc Med 2020 May 28. Epub 2020 May 28.

Helmsley Electrophysiology Center, Division of Cardiology, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America.

Background And Purpose: A novel, permanent, bilateral, common carotid artery (CCA) coil filter implant was designed to capture stroke-producing emboli in atrial fibrillation patients. Under ultrasound guidance, it is automatically deployed through a 24-guage needle and is retrievable up to 4 h post-procedure. We assessed the feasibility, safety, and effectiveness of the CCA filter in pre-clinical testing. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.05.031DOI Listing

Percutaneous repositioning of Impella mechanical circulatory support device: Snare-direct-push technique.

Cardiovasc Revasc Med 2019 Sep 6. Epub 2019 Sep 6.

Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2019.09.002DOI Listing
September 2019

Association between flow impairment in dominant coronary atrial branches and atrial arrhythmias in patients with ST-segment elevation myocardial infarction.

Cardiovasc Revasc Med 2020 May 29. Epub 2020 May 29.

Department of Cardiology, Leiden University Medical Center, 2300 RC Leiden, the Netherlands. Electronic address:

Objectives: The impact of atrial ischemia in the occurrence of atrial arrhythmias may vary based on the amount of jeopardized myocardium. We sought to determine the association between coronary flow impairment in dominant coronary atrial branches (CAB) and atrial arrhythmias at 1-year follow-up in ST-segment elevation myocardial infarction (STEMI) patients.

Methods: Patients with STEMI involving the right or circumflex coronary artery were included. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.05.036DOI Listing